Skye Bioscience, Inc. also files under EMBI, NMUS, LGLRD, LGLR; those filings are included. Filings under SKYE by Skye International, Inc (CIK 0001095751) from Apr 27, 2007 to Apr 27, 2007 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 33K | $1.91 | $62K |
| Sep 16, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 33K | $1.91 | $62K |
| Sep 16, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 1K | $1.91 | $2K |
| Sep 16, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 1K | $1.91 | $2K |
| Aug 20, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 46 | $0.32 | $15 |
| Aug 20, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 1K | $0.32 | $371 |
| Aug 20, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 46 | $0.32 | $15 |
| Aug 20, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 1K | $0.32 | $371 |
| Aug 20, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 6K | $0.32 | $2K |
| Aug 20, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 6K | $0.32 | $2K |
| Aug 19, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 57K | $0.35 | $20K |
| Aug 19, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 409 | $0.35 | $143 |
| Aug 19, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 409 | $0.35 | $143 |
| Aug 19, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 10K | $0.35 | $4K |
| Aug 19, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 10K | $0.35 | $4K |
| Aug 19, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 57K | $0.35 | $20K |
| Aug 18, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 253K | $0.38 | $96K |
| Aug 18, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 253K | $0.38 | $96K |
| Aug 18, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 2K | $0.38 | $695 |
| Aug 18, 2026 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 45K | $0.38 | $17K |
| Aug 18, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 2K | $0.38 | $695 |
| Aug 18, 2026 | 5AM Partners VII, LLC | 10% Owner | Sell(S) | 45K | $0.38 | $17K |
| Aug 7, 2026 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 1.1M | — | $0 |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Grant(A) | 22K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Disposed to issuer(D) | 9K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 9K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Grant(A) | 7K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Grant(A) | 12K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Disposed to issuer(D) | 150K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Disposed to issuer(D) | 200K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 250K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Grant(A) | 9K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Disposed to issuer(D) | 250K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 36K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Disposed to issuer(D) | 7K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Disposed to issuer(D) | 9K | — | — |
| Mar 31, 2026 | Charych Deborah H. | Director | Grant(A) | 75K | — | $0 |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 12K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 125K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 650K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Disposed to issuer(D) | 125K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Disposed to issuer(D) | 12K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 22K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Disposed to issuer(D) | 12K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Disposed to issuer(D) | 150K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Grant(A) | 150K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Disposed to issuer(D) | 22K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Disposed to issuer(D) | 22K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Grant(A) | 125K | — | — |
| Mar 31, 2026 | Schwab Andrew J. | Director | Grant(A) | 75K | — | $0 |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Grant(A) | 75K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Grant(A) | 17K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Disposed to issuer(D) | 75K | — | — |
| Mar 31, 2026 | Grayson Paul A. | Director | Grant(A) | 75K | — | $0 |
| Mar 31, 2026 | Jenkins Annalisa | Director | Grant(A) | 75K | — | $0 |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Grant(A) | 7K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Disposed to issuer(D) | 650K | — | — |
| Mar 31, 2026 | Smith Karen L. | Director | Grant(A) | 75K | — | $0 |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Grant(A) | 75K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Grant(A) | 150K | — | — |
| Mar 31, 2026 | Dhillon Punit | Chief Executive Officer, Director | Disposed to issuer(D) | 36K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Disposed to issuer(D) | 8K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Disposed to issuer(D) | 125K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Disposed to issuer(D) | 7K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Disposed to issuer(D) | 75K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Grant(A) | 200K | — | — |
| Mar 31, 2026 | Twitty Christopher | Chief Scientific Officer | Disposed to issuer(D) | 17K | — | — |
| Mar 31, 2026 | Diep Tuan Tu | Chief Operating Officer | Grant(A) | 8K | — | — |
| Feb 6, 2026 | Arsenault Kaitlyn | Chief Financial Officer | Grant(A) | 125K | — | $0 |
| Feb 6, 2026 | Diep Tuan Tu | Chief Development Officer | Grant(A) | 125K | — | $0 |
| Feb 6, 2026 | Twitty Christopher | Chief Scientific Officer | Grant(A) | 150K | — | $0 |
| Feb 6, 2026 | Charych Deborah H. | Director | Grant(A) | 35K | — | $0 |
| Feb 6, 2026 | Arora Puneet S. | Chief Medical Officer | Grant(A) | 125K | — | $0 |
| Feb 6, 2026 | Schwab Andrew J. | Director | Grant(A) | 35K | — | $0 |
| Feb 6, 2026 | Grayson Paul A. | Director | Grant(A) | 35K | — | $0 |
| Feb 6, 2026 | Jenkins Annalisa | Director | Grant(A) | 35K | — | $0 |
| Feb 6, 2026 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 280K | — | $0 |
| Feb 6, 2026 | Smith Karen L. | Director | Grant(A) | 35K | — | $0 |
| Aug 22, 2025 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 6K | $3.42 | $22K |
| Aug 22, 2025 | Rocklage Scott M | 10% Owner | Sell(S) | 6K | $3.42 | $22K |
| Aug 22, 2025 | Rocklage Scott M | 10% Owner | Sell(S) | 164K | $3.42 | $561K |
| Aug 22, 2025 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 164K | $3.42 | $561K |
| Aug 21, 2025 | Rocklage Scott M | 10% Owner | Sell(S) | 2K | $3.57 | $8K |
| Aug 21, 2025 | Rocklage Scott M | 10% Owner | Sell(S) | 59K | $3.57 | $209K |
| Aug 21, 2025 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 2K | $3.57 | $8K |
| Aug 21, 2025 | Schwab Andrew J. | Director, 10% Owner | Sell(S) | 59K | $3.57 | $209K |
| Feb 24, 2025 | Arora Puneet S. | Chief Medical Officer | Grant(A) | 38K | — | $0 |
| Feb 24, 2025 | Grayson Paul A. | Director | Grant(A) | 135K | — | $0 |
| Feb 24, 2025 | Schwab Andrew J. | Director | Grant(A) | 35K | — | $0 |
| Feb 24, 2025 | Arsenault Kaitlyn | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Feb 24, 2025 | Jenkins Annalisa | Director | Grant(A) | 35K | — | $0 |
| Feb 24, 2025 | Smith Karen L. | Director | Grant(A) | 35K | — | $0 |
| Feb 24, 2025 | Dhillon Punit | Chief Executive Officer, Director | Grant(A) | 250K | — | $0 |
| Feb 24, 2025 | Charych Deborah H. | Director | Grant(A) | 35K | — | $0 |
| Feb 24, 2025 | Diep Tuan Tu | Chief Development Officer | Grant(A) | 150K | — | $0 |
| Nov 18, 2024 | Arsenault Kaitlyn | Chief Financial Officer | Sell(S) | 43K | $4.99 | $215K |
| Nov 18, 2024 | Diep Tuan Tu | Chief Development Officer | Sell(S) | 19K | $4.99 | $97K |
| Nov 18, 2024 | Dhillon Punit | Chief Executive Officer, Director | Sell(S) | 83K | $4.99 | $412K |
| Nov 18, 2024 | Grayson Paul A. | Director | Sell(S) | 86K | $4.99 | $430K |
| Nov 15, 2024 | Arsenault Kaitlyn | Chief Financial Officer | Sell(S) | 190 | $5.55 | $1K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Skye Bioscience, Inc., SEC CIK 0001516551. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under SKYE and shows every filing by that issuer (also filed as EMBI, NMUS, LGLRD, LGLR). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-19. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SKYE